Market – Page 5

Eli Lilly Announces $15 Billion Share Buyback Plan and 15% Dividend Increase

6 months ago talkbio0Tagged dividend, Drug Industry, Eli, Eli Lilly, Increase, Market, Share Buyback

Eli Lilly, Share Buyback, Dividend Increase, Pharmaceutical Industry, Stock Market

BeiGene Secures Long-Term Protection for BRUKINSA with Patent Settlement Until 2037

7 months ago talkbio0Tagged BeiGene, Brukinsa, BTK gene, Cancer Therapeutic Procedure, competition, exclusivity, Inhibitor, Market, MSN gene, Patent Settlement

BeiGene, BRUKINSA, patent settlement, MSN Pharmaceuticals, generic competition, market exclusivity, BTK inhibitor, cancer treatment

Unlocking Health Equity: Leveraging Comprehensive SDOH Market Insights for Enhanced Treatment, Access, and Adherence

7 months ago talkbio0Tagged Adherence, Adherence (attribute), Data Analytics, Health care facility, Health Equity, Market, outcomes, public health medicine (field), Social Determinants of Health

Social Determinants of Health (SDOH), Health Equity, Market Insights, Treatment Access, Adherence, Healthcare Outcomes, Data Analytics, Public Health

Vaccine Stocks Plummet Globally Following RFK Jr.’s Nomination to Head HHS

7 months ago talkbio0Tagged Appointments, CHARGE Syndrome, Impact food supplement, Market, pharmaceutical companies, RFK Jr., stocks, Vaccines

RFK Jr., HHS appointment, vaccine stocks, pharmaceutical companies, stock market impact

Pharmaceutical Giants Eli Lilly and Novo Nordisk Face Challenges Despite Strong Sales Growth

7 months ago talkbio0Tagged competition, Drug Industry, Eli, Eli Lilly, financial results, issues, Market, Nordisk, Obesity, Pricing, Q3 2024, Weight loss therapies

Eli Lilly, Novo Nordisk, Q3 2024 financial results, Obesity drugs, Weight loss therapies, Pharmaceutical industry challenges, Market competition, Supply pressures, Pricing issues

European Commission Imposes €463 Million Fine on Teva for Anti-Competitive Practices in MS Drug Market

7 months ago talkbio0Tagged Commission, competition, Copaxone, Dominance, European (ethnic group), Market, Mississippi (geographic location), MS, tactics, Teva

Teva, European Commission, fine, MS drug, competition tactics, Copaxone, market dominance

Vabysmo’s Growth Pace Slows in Q3, Still on Track for Dominance in Eye Disease Market

8 months ago talkbio0Tagged Age related macular degeneration, Macular edema due to diabetes mellitus, Market, Regeneron, Roche (company), Vabysmo, Vascular Endothelial Growth Factor A

Vabysmo, Roche, Regeneron, Eylea HD, eye disease market, vascular endothelial growth factor A (VEGF-A) therapy, age-related macular degeneration (AMD), diabetic macular edema (DME).